Cargando…

Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer

OBJECTIVE: Immune checkpoint inhibitors have been widely used in the treatment of endometrial cancer (EC) with microsatellite instability-hypermutated (MSI-H). However, there is an unmet need for microsatellite stable (MSS) EC because of their modest activity. This study aimed to identify potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Jin Hwa, Cho, Hyun Woong, Ouh, Yung-Taek, Lee, Jae Kwan, Chun, Yikyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995863/
https://www.ncbi.nlm.nih.gov/pubmed/36509464
http://dx.doi.org/10.3802/jgo.2023.34.e18